Esophageal Cancer Market (Treatment Type: Chemotherapy, Radiation Therapy, Targeted Therapy, Immunotherapy, and Others, and Stage of Cancer: Early-stage Esophageal Cancer and Advanced Esophageal Cancer) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
Esophageal Cancer Market – Scope of Report TMR’s report on the global esophageal cancer market studies the past as well as the current growth trends and opportunities to gain valuable insights of ... もっと見る
日本語のページは自動翻訳を利用し作成しています。
SummaryEsophageal Cancer Market – Scope of ReportTMR’s report on the global esophageal cancer market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global esophageal cancer market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global esophageal cancer market from 2024 to 2034. The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the esophageal cancer market. Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global esophageal cancer market. The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global esophageal cancer market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global esophageal cancer market. The report delves into the competitive landscape of the global esophageal cancer market. Key players operating in the global esophageal cancer market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global esophageal cancer market profiled in this report. Key Questions Answered in Global esophageal cancer Market Report • What is the sales/revenue generated by esophageal cancer across all regions during the forecast period? • What are the opportunities in the global esophageal cancer market? • What are the major drivers, restraints, opportunities, and threats in the market? • Which regional market is set to expand at the fastest CAGR during the forecast period? • Which segment is expected to generate the highest revenue globally in 2034? • Which segment is projected to expand at the highest CAGR during the forecast period? • What are the market positions of different companies operating in the global market? Esophageal Cancer Market – Research Objectives and Research Approach The comprehensive report on the global esophageal cancer market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period. The report analyzes the global esophageal cancer market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global esophageal cancer market. Table of Contents1. Preface1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Esophageal Cancer Market 4. Market Overview 4.1. Introduction 4.1.1. Product Definition 4.1.2. Industry Evolution/Developments 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Esophageal Cancer Market Analysis and Forecast, 2020-2034 5. Key Insights 5.1. Pipeline Analysis 5.2. Key Product /Brand Analysis 5.3. Key Mergers & Acquisitions 5.4. COVID-19 Pandemic Impact on Industry 6. Global Esophageal Cancer Market Analysis and Forecast, by Treatment Type 6.1. Introduction & Definition 6.2. Key Findings/Developments 6.3. Market Value Forecast, by Treatment Type, 2020-2034 6.3.1. Chemotherapy 6.3.2. Radiation Therapy 6.3.3. Targeted Therapy 6.3.4. Immunotherapy 6.3.5. Others 6.4. Market Attractiveness Analysis, by Treatment Type 7. Global Esophageal Cancer Market Analysis and Forecast, by Stage of Cancer 7.1. Introduction & Definition 7.2. Key Findings/Developments 7.3. Market Value Forecast, by Stage of Cancer, 2020-2034 7.3.1. Early-stage Esophageal Cancer 7.3.2. Advanced Esophageal Cancer 7.4. Market Attractiveness Analysis, by Stage of Cancer 8. Global Esophageal Cancer Market Analysis and Forecast, by End-user 8.1. Introduction & Definition 8.2. Key Findings/Developments 8.3. Market Value Forecast, by End-user, 2020-2034 8.3.1. Hospitals 8.3.2. Specialty Clinics 8.3.3. Cancer Treatment Centers 8.3.4. Ambulatory Surgical Centers 8.4. Market Attractiveness Analysis, by End-user 9. Global Esophageal Cancer Market Analysis and Forecast, by Region 9.1. Key Findings 9.2. Market Value Forecast, by Region, 2020-2034 9.2.1. North America 9.2.2. Europe 9.2.3. Asia Pacific 9.2.4. Latin America 9.2.5. Middle East & Africa 9.3. Market Attractiveness Analysis, by Region 10. North America Esophageal Cancer Market Analysis and Forecast 10.1. Introduction 10.2. Key Findings 10.3. Market Value Forecast, by Treatment Type, 2020-2034 10.3.1. Chemotherapy 10.3.2. Radiation Therapy 10.3.3. Targeted Therapy 10.3.4. Immunotherapy 10.3.5. Others 10.4. Market Value Forecast, by Stage of Cancer, 2020-2034 10.4.1. Early-stage Esophageal Cancer 10.4.2. Advanced Esophageal Cancer 10.5. Market Value Forecast, by End-user, 2020-2034 10.5.1. Hospitals 10.5.2. Specialty Clinics 10.5.3. Cancer Treatment Centers 10.5.4. Ambulatory Surgical Centers 10.6. Market Value Forecast, by Country, 2020-2034 10.6.1. U.S. 10.6.2. Canada 10.7. Market Attractiveness Analysis 10.7.1. By Treatment Type 10.7.2. By Stage of Cancer 10.7.3. By End-user 10.7.4. By Country 11. Europe Esophageal Cancer Market Analysis and Forecast 11.1. Introduction 11.2. Key Findings 11.3. Market Value Forecast, by Treatment Type, 2020-2034 11.3.1. Chemotherapy 11.3.2. Radiation Therapy 11.3.3. Targeted Therapy 11.3.4. Immunotherapy 11.3.5. Others 11.4. Market Value Forecast, by Stage of Cancer, 2020-2034 11.4.1. Early-stage Esophageal Cancer 11.4.2. Advanced Esophageal Cancer 11.5. Market Value Forecast, by End-user, 2020-2034 11.5.1. Hospitals 11.5.2. Specialty Clinics 11.5.3. Cancer Treatment Centers 11.5.4. Ambulatory Surgical Centers 11.6. Market Value Forecast, by Country/Sub-region, 2020-2034 11.6.1. Germany 11.6.2. U.K. 11.6.3. France 11.6.4. Italy 11.6.5. Spain 11.6.6. Rest of Europe 11.7. Market Attractiveness Analysis 11.7.1. By Treatment Type 11.7.2. By Stage of Cancer 11.7.3. By End-user 11.7.4. By Country/Sub-region 12. Asia Pacific Esophageal Cancer Market Analysis and Forecast 12.1. Introduction 12.2. Key Findings 12.3. Market Value Forecast, by Treatment Type, 2020-2034 12.3.1. Chemotherapy 12.3.2. Radiation Therapy 12.3.3. Targeted Therapy 12.3.4. Immunotherapy 12.3.5. Others 12.4. Market Value Forecast, by Stage of Cancer, 2020-2034 12.4.1. Early-stage Esophageal Cancer 12.4.2. Advanced Esophageal Cancer 12.5. Market Value Forecast, by End-user, 2020-2034 12.5.1. Hospitals 12.5.2. Specialty Clinics 12.5.3. Cancer Treatment Centers 12.5.4. Ambulatory Surgical Centers 12.6. Market Value Forecast, by Country/Sub-region, 2020-2034 12.6.1. China 12.6.2. Japan 12.6.3. India 12.6.4. Australia & New Zealand 12.6.5. Rest of Asia Pacific 12.7. Market Attractiveness Analysis 12.7.1. By Treatment Type 12.7.2. By Stage of Cancer 12.7.3. By End-user 12.7.4. By Country/Sub-region 13. Latin America Esophageal Cancer Market Analysis and Forecast 13.1. Introduction 13.2. Key Findings 13.3. Market Value Forecast, by Treatment Type, 2020-2034 13.3.1. Chemotherapy 13.3.2. Radiation Therapy 13.3.3. Targeted Therapy 13.3.4. Immunotherapy 13.3.5. Others 13.4. Market Value Forecast, by Stage of Cancer, 2020-2034 13.4.1. Early-stage Esophageal Cancer 13.4.2. Advanced Esophageal Cancer 13.5. Market Value Forecast, by End-user, 2020-2034 13.5.1. Hospitals 13.5.2. Specialty Clinics 13.5.3. Cancer Treatment Centers 13.5.4. Ambulatory Surgical Centers 13.6. Market Value Forecast, by Country/Sub-region, 2020-2034 13.6.1. Brazil 13.6.2. Mexico 13.6.3. Rest of Latin America 13.7. Market Attractiveness Analysis 13.7.1. By Treatment Type 13.7.2. By Stage of Cancer 13.7.3. By End-user 13.7.4. By Country/Sub-region 14. Middle East & Africa Esophageal Cancer Market Analysis and Forecast 14.1. Introduction 14.2. Key Findings 14.3. Market Value Forecast, by Treatment Type, 2020-2034 14.3.1. Chemotherapy 14.3.2. Radiation Therapy 14.3.3. Targeted Therapy 14.3.4. Immunotherapy 14.3.5. Others 14.4. Market Value Forecast, by Stage of Cancer, 2020-2034 14.4.1. Early-stage Esophageal Cancer 14.4.2. Advanced Esophageal Cancer 14.5. Market Value Forecast, by End-user, 2020-2034 14.5.1. Hospitals 14.5.2. Specialty Clinics 14.5.3. Cancer Treatment Centers 14.5.4. Ambulatory Surgical Centers 14.6. Market Value Forecast, by Country/Sub-region, 2020-2034 14.6.1. GCC Countries 14.6.2. South Africa 14.6.3. Rest of Middle East & Africa 14.7. Market Attractiveness Analysis 14.7.1. By Treatment Type 14.7.2. By Stage of Cancer 14.7.3. By End-user 14.7.4. By Country/Sub-region 15. Competition Landscape 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies) 15.2. Market Share Analysis, by Company (2023) 15.3. Company Profiles 15.3.1. Bristol-Myers Squibb Company 15.3.1.1. Company Overview 15.3.1.2. Product Portfolio 15.3.1.3. SWOT Analysis 15.3.1.4. Financial Overview 15.3.1.5. Strategic Overview 15.3.2. Merck & Co., Inc. 15.3.2.1. Company Overview 15.3.2.2. Product Portfolio 15.3.2.3. SWOT Analysis 15.3.2.4. Financial Overview 15.3.2.5. Strategic Overview 15.3.3. Eli Lilly and Company 15.3.3.1. Company Overview 15.3.3.2. Product Portfolio 15.3.3.3. SWOT Analysis 15.3.3.4. Financial Overview 15.3.3.5. Strategic Overview 15.3.4. AstraZeneca plc 15.3.4.1. Company Overview 15.3.4.2. Product Portfolio 15.3.4.3. SWOT Analysis 15.3.4.4. Financial Overview 15.3.4.5. Strategic Overview 15.3.5. F. Hoffmann-La Roche AG 15.3.5.1. Company Overview 15.3.5.2. Product Portfolio 15.3.5.3. SWOT Analysis 15.3.5.4. Financial Overview 15.3.5.5. Strategic Overview 15.3.6. Pfizer Inc. 15.3.6.1. Company Overview 15.3.6.2. Product Portfolio 15.3.6.3. SWOT Analysis 15.3.6.4. Financial Overview 15.3.6.5. Strategic Overview 15.3.7. Novartis AG 15.3.7.1. Company Overview 15.3.7.2. Product Portfolio 15.3.7.3. SWOT Analysis 15.3.7.4. Financial Overview 15.3.7.5. Strategic Overview 15.3.8. Sanofi S.A. 15.3.8.1. Company Overview 15.3.8.2. Product Portfolio 15.3.8.3. SWOT Analysis 15.3.8.4. Financial Overview 15.3.8.5. Strategic Overview 15.3.9. The Takeda Pharmaceutical Company Limited 15.3.9.1. Company Overview 15.3.9.2. Product Portfolio 15.3.9.3. SWOT Analysis 15.3.9.4. Financial Overview 15.3.9.5. Strategic Overview 15.3.10. Bayer AG 15.3.10.1. Company Overview 15.3.10.2. Product Portfolio 15.3.10.3. SWOT Analysis 15.3.10.4. Financial Overview 15.3.10.5. Strategic Overview
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポートTransparency Market Research 社の最新刊レポート
本レポートと同じKEY WORD(chemotherapy)の最新刊レポート
よくあるご質問Transparency Market Research社はどのような調査会社ですか?トレンスペアレンシーマーケットリサーチ(Transparency Market Research /TMR)は市場参入やホワイトスペースの特定、新商品や新サービスの立ち上げ、戦略的M&Aなどの実現のた... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/09/25 10:28 144.33 円 161.91 円 196.41 円 |